The American Society for Clinical Oncology’s Annual Meeting for 2025 is, if nothing else, absolutely overwhelming and ...

In 2018, the FDA began an investigation into nitrosamine impurities in drugs that led to high-profile recalls for heartburn ...

Notably, the U.S.’ two primary biopharma trade groups—the Pharmaceutical Research and Manufacturers of America (PhRMA) and ...

Indian CDMOs are strategically expanding through acquisitions in the US and Europe, driven by global pharma's nearshoring ...

On the 30th of last month, the Korea Pharmaceutical and Biological Association held a 'KPBMA Ethics Management Workshop' at ...

Since President Donald J. Trump took office a second time on Jan. 20, leaders across the biotechnology and pharmaceutical ...

Sourcing and procurement executives in bio/pharmaceutical companies: Gain insights for selecting and managing supply base components. Investors, advisors, and consultants: Acquire a deeper ...

The Hyderabad-based BSE smallcap company's revenue from operations surged by 23 per cent to ₹128.2 crore, compared to ₹104.1 ...

Telesis Bio has announced a licensing agreement with Regeneron, enabling the latter to deploy the Gibson SOLA platform at R&D ...

Instil Bio (TIL) has announced the appointment of Jamie Freedman as Chief Medical Officer.  Jamie Freedman is a Hematologist-Oncologist and a highly experienced biopharmaceutical executive.

Pharmaceutical manufacturer Sigachi Industries has announced a 10 per cent final dividend for FY25 after posting a strong Q4 ...